✦ LIBER ✦

Histone deacetylase as a therapeutic target

✍ Scribed by Oliver H. Krämer; Martin Göttlicher; Thorsten Heinzel

Book ID: 117699882
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 623 KB
Volume: 12
Category: Article
ISSN: 1043-2760
DOI: 10.1016/s1043-2760(01)00438-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histone deacetylase as a therapeutic tar

Histone deacetylase as a therapeutic target in hemorrhagic shock: Effects of fluid resuscitation strategies

✍ T. Lin; E. Koustova; J.R. Kirkpatrick; H. Chen; H.B. Alam 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Histone deacetylase 3 as a novel therape

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

✍ Minami, J; Suzuki, R; Mazitschek, R; Gorgun, G; Ghosh, B; Cirstea, D; Hu, Y; Mim 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 1021 KB

Histone deacetylase as therapeutic targe

Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: Effect of different resuscitation strategies on lung and liver

✍ Tom Lin; Huazhen Chen; Elena Koustova; Elizabeth A. Sailhamer; Yongqing Li; Chri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 493 KB

NAD+-dependent histone deacetylases (sir

NAD+-dependent histone deacetylases (sirtuins) as novel therapeutic targets

✍ Jörg Schemies; Urszula Uciechowska; Wolfgang Sippl; Manfred Jung 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

Histone deacetylases (HDACs) are enzymes that cleave off acetyl groups from acetyl-lysine residues in histones and various nonhistone proteins. Four different classes of HDACs have been identified in humans so far. Although classes I, II, and IV are zinc-dependent amidohydrolases, class III HDACs de

Histone Deacetylase: A Potential Therape

Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders

✍ Pang, M.; Zhuang, S. 📂 Article 📅 2010 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 183 KB

ChemInform Abstract: NAD+-Dependent Hist

ChemInform Abstract: NAD+-Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets

✍ Joerg Schemies; Urszula Uciechowska; Wolfgang Sippl; Manfred Jung 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 20 KB